AIkido Pharma Inc. (AIKI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

0.3061

-0.0038

(-1.23%)

As of 03:56PM EDT. Market open.

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Short-term KST

View all chart patterns

Performance Outlook

Previous Close	0.3099
Open	0.3052
Bid	0.3060 x 800
Ask	0.3099 x 800
Day's Range	0.3000 - 0.3110
52 Week Range	0.2900 - 1.2100
Volume	593,074
Avg. Volume	1,725,741

Market Cap	27.333M
Beta (5Y Monthly)	1.56
PE Ratio (TTM)	N/A
EPS (TTM)	-0.1090
Earnings Date	Aug 09, 2022 - Aug 15, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	May 12, 1980
1y Target Est	2.00

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for AIKI

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

AIkido Pharma Inc.
Daily – Vickers Top Buyers & Sellers for 05/03/2021The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Rating
Fair Value
Economic Moat
last yearArgus Research

All

PR Newswire
AIkido Pharma Announces Company Commitment to Board Diversity
AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced the Company's commitment to complying with the NASDAQ listing requirements on board diversity by August 1, 2022.
- QPR Software Plc’s Board of Directors has decided on a rights offering and is publishing the terms and conditions
  GlobeNewswire
- 50/50 Women on Boards™ Recognizes LKQ as a “3+” Company, with Three or More Women Directors
  GlobeNewswire
PR Newswire
AIkido Pharma Secures Interest in Databricks Inc.
AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the Company, through a fund that owns the stock, has acquired an economic interest in privately held Databricks Inc. (https://databricks.com/company/about-us). The acquisition has been funded and closed, and the asset is on the Company's balance sheet.
Simply Wall St.
AIkido Pharma (NASDAQ:AIKI) Is In A Good Position To Deliver On Growth Plans
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...